Skip to main content

Table 1 Clinical characteristics of the 385 patients with nasopharyngeal carcinoma (NPC) who were treated with intensity-modulated radiotherapy (IMRT)

From: Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy

Characteristic

No. of patients (%)

Sex

 Man

281 (73.0)

 Woman

104 (27.0)

Age (years)

 ≤ 45

235 (61.0)

 > 45

150 (39.0)

Histological type

 WHO type I

3 (0.8)

 WHO type II/III

382 (99.2)

T categorya

 T1

73 (19.0)

 T2

75 (19.5)

 T3

168 (43.6)

 T4

69 (17.9)

N categorya

 N0

53 (13.8)

 N1

244 (63.4)

 N2

62 (16.1)

 N3

26 (6.7)

Clinical stagea

 I

23 (6.0)

 II

98 (25.4)

 III

172 (44.7)

 IVB

92 (23.9)

Chemotherapy

 No

55 (14.3)

 Yes

330 (85.7)

  1. WHO World Health Organization
  2. aStaged according to the 7th edition of the Union for International Cancer Control and American Joint Committee on Cancer (UICC/AJCC) staging system